Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group
Year: 2022
Type: article
Authors: Stuart McPherson, Matthew J Armstrong, Jeremy F Cobbold, Lynsey Corless, Quentin M Anstee, Richard J Aspinall, Stephen T Barclay, Paul N Brennan, Tessa M Cacciottolo, Robert D Goldin, Kate Hallsworth, Vanessa Hebditch, Kathryn Jack, Helen Jarvis, Jill Johnson, Wenhao Li, Dina Mansour, Mary McCallum, Ashis Mukhopadhya, Richard Parker, Valerie Ross, Ian A Rowe, Ankur Srivastava, Prarthana Thiagarajan, Alexandra I Thompson, Jeremy Tomlinson, Emmanuel A Tsochatzis, Andrew Yeoman, William Alazawi
Institutions: Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne Hospital, Newcastle University, Queen Elizabeth Hospital Birmingham, NIHR Birmingham Liver Biomedical Research Unit, NIHR Birmingham Biomedical Research Centre, University of Birmingham, University of Oxford, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, University of Hull, Queen Alexandra Hospital, NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, MRC Centre for Regenerative Medicine, University of Edinburgh, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Wellcome/MRC Institute of Metabolic Science, Imperial College London, British Liver Trust, Nottingham University Hospitals NHS Trust, Queen Mary University of London, Barts Health NHS Trust, Queen Elizabeth Hospital, Aberdeen Royal Infirmary, St James's University Hospital, University of Leeds, North Bristol NHS Trust, Southmead Hospital, Edinburgh Royal Infirmary, Oxford Centre for Diabetes, Endocrinology and Metabolism, The Royal Free Hospital, University College London, Aneurin Bevan University Health Board
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G1731376943, G2301776639, Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt - NAFLD), G357689415, G4613715315, Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt - NAFLD), Delivering the first evidence based lifestyle service pathway for people with non-alcoholic fatty liver disease (NAFLD), Development and evaluation of a framework for managing liver disease in primary care, NIHR Development and Skills Enhancement Award
OpenAlex ID: W4225096501